Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1692690Generated: October 27, 2026

Acetic Acid → 4-(2-Chloro-9-methyl-8-((4-(methylsulfonyl)piperazin-1-yl)methyl)-9H-purin-6-yl)morpholine

https://huagongshe.com/reaction/1692690

Reaction equation

Participants

RoleNameHCIDCharge
ReactantAcetic AcidHCID 176—
ReactantTrimethyl orthoformateHCID 9005—
Reactant1-(Methylsulfonyl)piperazineHCID 709161—
ReactantSodium triacetoxyborohydrideHCID 5049666—
Reactant2-Chloro-9-methyl-6-morpholino-9H-purine-8-carbaldehydeHCID 59603472—
Solvent1,1-DichloroethaneHCID 6365—
Product4-(2-Chloro-9-methyl-8-((4-(methylsulfonyl)piperazin-1-yl)methyl)-9H-purin-6-yl)morpholineHCID 86637242—

Reaction Steps

2-Chloro-9-methyl-6-morpholino-9H-purine-8-carbaldehyde was treated with 1.1 eq 1-(methylsulfonyl)piperazine, 7 eq trimethylorthoformate, 1 eq of acetic acid in 2 mL of dichloroethane for 6 hours upon which 1.1 eq of sodium triacetoxyborohydride was added to the reaction mixture. The reaction mixture was extracted with dichloromethane and water to give crude intermediate 4-(2-chloro-9-methyl-8-((4 (methylsulfonyl)piperazin-1-yl)methyl)-9H-purin-6-yl)morpholine which was then reacted with 1-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole via General Procedure A and purified via reverse phase HPLC to give 41.8 mg 138 as a white solid. MS (Q1) 512.2 (M)+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08158624B2
Source datasetuspto-grants-2012_04
ORD IDord-91bf1a31a29844ce8876b8f07a94518d
Source noteuspto-grants-2012_04